Preferred Label : quinazolines;

MeSH definition : A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring.;

MeSH synonym : Quinazoline;

Is substance : O;

Details


Main resources

You can consult :

A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring.

https://ansm.sante.fr/tableau-marr/vandetanib
2024
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
RET Gene Mutation
guidelines for drug use
piperidines
quinazolines
piperidines
quinazolines

---
https://ansm.sante.fr/tableau-atu-rtu/tucatinib-50-mg-comprime-pellicule
2021
false
false
false
France
French
administration, oral
summary of product characteristics
package leaflet
guidelines for drug use
antineoplastic agents
protein kinase inhibitors
tucatinib
Tucatinib
Tucatinib
oxazoles
pyridines
quinazolines
antineoplastic combined chemotherapy protocols
adult
breast neoplasms
Trastuzumab
Capecitabine
Capecitabine/Trastuzumab/Tucatinib Regimen
neoplasm metastasis
receptor, erbB-2
tucatinib
tucatinib
HER2-Positive Breast Carcinoma
oxazoles
pyridines
quinazolines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tukysa
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
oxazoles
oxazoles
pyridines
pyridines
quinazolines
quinazolines
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
tucatinib
receptor, erbB-2
risk management
product surveillance, postmarketing
breast neoplasms
neoplasm metastasis
HER2-positive metastatic breast cancer
antineoplastic combined chemotherapy protocols
Capecitabine/Trastuzumab/Tucatinib Regimen
administration, oral
adult
aged
continuity of patient care
drug interactions
pregnancy
breast feeding
survival analysis
drug evaluation, preclinical
tucatinib
tucatinib
HER2-Positive Breast Carcinoma
Tyrosine Kinase Inhibitors

---
https://www.has-sante.fr/jcms/p_3273459/fr/tukysa-tucatinib
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
tucatinib
antineoplastic agents
protein kinase inhibitors
tucatinib
antineoplastic combined chemotherapy protocols
Trastuzumab
Capecitabine
Capecitabine/Trastuzumab/Tucatinib Regimen
adult
breast neoplasms
HER2-Positive Breast Carcinoma
evaluation of the transparency committee
oxazoles
pyridines
quinazolines

---
https://www.has-sante.fr/jcms/p_3145048/fr/anagrelide
2020
false
false
false
France
administration, oral
anagrelide
thrombocythemia, essential
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
anagrelide
quinazolines

---
https://www.has-sante.fr/portail/jcms/c_2912132/fr/caprelsa
2019
false
true
false
false
France
administration, oral
treatment outcome
vandetanib
insurance, health, reimbursement
protein kinase inhibitors
adult
adolescent
child
thyroid cancer, medullary
neoplasm metastasis
caprelsa
piperidines
quinazolines
evaluation of the transparency committee
vandetanib
piperidines
quinazolines
carcinoma, neuroendocrine
thyroid neoplasms

---
Prevymis letermovir
https://www.ema.europa.eu/medicines/human/EPAR/Prevymis
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
letermovir
drug approval
europe
treatment outcome
orphan drug production
hematopoietic stem cell transplantation
allografts
Allogeneic Hematopoietic Stem Cell Transplantation
antiviral agents
antiviral agents
cytomegalovirus infections
Cytomegalovirus infection reactivation
administration, oral
infusions, intravenous
terminase
enzyme inhibitors
enzyme inhibitors
pregnancy
breast feeding
drug interactions
letermovir
product surveillance, postmarketing
adult
aged
drug evaluation, preclinical
letermovir
letermovir
acetates
quinazolines
letermovir
endodeoxyribonucleases
acetates
quinazolines

---
https://www.ema.europa.eu/medicines/human/EPAR/Anagrelide-Mylan
2018
false
United Kingdom
French
English
syndication feed
drugs, generic
anagrelide
drug approval
europe
drug interactions
pregnancy
breast feeding
Anagrelide hydrochloride 500micrograms capsule (product)
Product containing precisely anagrelide hydrochloride 1 milligram/1 each conventional release oral capsule (clinical drug)
thrombocythemia, essential
treatment outcome
anagrelide
quinazolines
anagrelide
administration, oral
quinazolines
drug evaluation
summary of product characteristics
package leaflet

---
https://www.has-sante.fr/portail/jcms/c_2869231/fr/prevymis
2018
false
false
false
France
French
treatment outcome
orphan drug production
hematopoietic stem cell transplantation
allografts
Allogeneic Hematopoietic Stem Cell Transplantation
antiviral agents
cytomegalovirus infections
Cytomegalovirus infection reactivation
administration, oral
infusions, intravenous
terminase
enzyme inhibitors
letermovir
adult
aged
evaluation of the transparency committee
insurance, health, reimbursement
letermovir
letermovir
acetates
quinazolines
endodeoxyribonucleases

---
http://www.has-sante.fr/portail/jcms/c_2755485/fr/xagrid
2017
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
anagrelide hydrochloride
anagrelide
quinazolines

---
http://www.has-sante.fr/portail/jcms/c_2640689/fr/giotrif
2016
false
false
false
France
French
administration, oral
afatinib
afatinib
Afatinib Dimaleate
afatinib
evaluation of the transparency committee
protein kinase inhibitors
protein kinase inhibitors
protein-tyrosine kinases
Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)
carcinoma, non-small-cell lung
treatment outcome
mutation
adult
neoplasm metastasis
EGFR protein, human
Advanced Malignant Neoplasm
insurance, health, reimbursement
Progression-Free survival
Tyrosine Kinase Inhibitors
disease-free survival
quinazolines
quinazolines
ErbB Receptors
Afatinib
Afatinib

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-EGFR-erlotinib-gefitinib-afatinib
2016
false
false
false
France
French
guidelines for drug use
patients guideline
practice guideline
antineoplastic agents
antineoplastic agents
antineoplastic agents
administration, oral
Erlotinib Hydrochloride
Erlotinib Hydrochloride
Erlotinib Hydrochloride
erlotinib
protein kinase inhibitors
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
drug interactions
pregnancy
carcinoma, non-small-cell lung
interdisciplinary communication
afatinib
afatinib
afatinib
afatinib
gefitinib
Tyrosine Kinase Inhibitors
quinazolines
quinazolines
quinazolines
ErbB Receptors
Gefitinib
Gefitinib
Gefitinib
Afatinib
Afatinib
Afatinib

---
http://www.meddispar.fr/Medicaments/GIOTRIF-30-B-28/(type)/letter/(value)/G/(cip)/3400927565700
2014
false
true
false
France
French
drug information
afatinib
administration, oral
drug prescriptions
legislation, drug
afatinib
continuity of patient care
drug monitoring
quinazolines
Afatinib

---
http://www.meddispar.fr/Medicaments/GIOTRIF-40-B-28/(type)/letter/(value)/G/(cip)/3400927565878
2014
false
true
false
France
French
drug information
administration, oral
legislation, drug
drug prescriptions
continuity of patient care
drug monitoring
afatinib
afatinib
quinazolines
Afatinib

---
http://www.meddispar.fr/Medicaments/GIOTRIF-20-B-28/(type)/letter/(value)/G/(cip)/3400927565649
2014
false
true
false
France
French
drug information
administration, oral
drug prescriptions
legislation, drug
continuity of patient care
drug monitoring
afatinib
afatinib
quinazolines
Afatinib

---
http://www.has-sante.fr/portail/jcms/c_1758545/fr/tomudex
2014
false
false
false
France
French
evaluation of the transparency committee
colorectal neoplasms
neoplasm metastasis
treatment outcome
raltitrexed
raltitrexed
raltitrexed
antimetabolites, antineoplastic
antimetabolites, antineoplastic
infusions, intravenous
disease progression
adult
survival analysis
raltitrexed
antimetabolites, antineoplastic
clinical trials as topic
quinazolines
thiophenes
quinazolines
thiophenes
quinazolines
thiophenes

---
http://www.has-sante.fr/portail/jcms/c_1730855/fr/giotrif-50-mg-comprime-afatinib-inhibiteur-de-tyrosine-kinase
http://www.has-sante.fr/portail/jcms/c_1730855/fr/giotrif-afatinib-inhibiteur-de-tyrosine-kinase
2014
false
false
false
France
French
administration, oral
afatinib
afatinib
Afatinib Dimaleate
afatinib
evaluation of the transparency committee
guidelines for drug use
protein kinase inhibitors
protein kinase inhibitors
protein-tyrosine kinases
Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)
carcinoma, non-small-cell lung
treatment outcome
mutation
adult
neoplasm metastasis
EGFR protein, human
Advanced Malignant Neoplasm
insurance, health, reimbursement
randomized controlled trials as topic
Progression-Free survival
Tyrosine Kinase Inhibitors
disease-free survival
quinazolines
quinazolines
ErbB Receptors
Afatinib
Afatinib

---
http://www.meddispar.fr/Medicaments/GIOTRIF-50-B-28/(type)/letter/(value)/G/(cip)/3400927565939
2014
false
true
false
France
French
drug information
administration, oral
drug prescriptions
legislation, drug
afatinib
afatinib
continuity of patient care
drug monitoring
quinazolines
Afatinib

---
https://www.ema.europa.eu/medicines/human/EPAR/Tyverb
2012
false
United Kingdom
English
French
syndication feed
Capecitabine
Anastrozole/Lapatinib Regimen
HER2-positive hormone receptor positive metastatic breast cancer in postmenopausal women
Exemestane/Lapatinib Regimen
Lapatinib/Letrozole Regimen
Capecitabine/Lapatinib Regimen
breast cancer whose tumours overexpress HER2 with hormone receptor-negative metastatic disease that has progressed
Lapatinib/Trastuzumab Regimen
protein kinase inhibitors
antineoplastic agents
breast neoplasms
quinazolines
neoplasm metastasis
antineoplastic combined chemotherapy protocols
tablets
administration, oral
drug approval
drug evaluation, preclinical
treatment outcome
drug labeling
antineoplastic agents
protein kinase inhibitors
receptor, erbB-2
antimetabolites, antineoplastic
drug interactions
pregnancy
breast feeding
food-drug interactions
quinazolines
lapatinib
lapatinib ditosylate
lapatinib ditosylate
summary of product characteristics
drug evaluation
package leaflet
Lapatinib
Lapatinib

---
https://www.ema.europa.eu/medicines/human/EPAR/Xagrid
2011
false
United Kingdom
French
English
syndication feed
drug approval
europe
adult
anagrelide
thrombocythemia, essential
treatment outcome
anagrelide
quinazolines
drug evaluation
anagrelide
administration, oral
quinazolines
drug evaluation
summary of product characteristics
package leaflet

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2009.06982/
2009
false
Switzerland
French
anagrelide
quinazolines
platelet aggregation inhibitors
thrombocytosis
quinazolines
journal article

---
http://www.meddispar.fr/medicaments/3651790
2008
France
French
quinazolines
drug prescriptions
legislation, drug
anagrelide
anagrelide
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65609052
2008
false
France
French
quinazolines
administration, oral
tablets
lapatinib ditosylate
lapatinib
drug information
Lapatinib

---
http://www.has-sante.fr/portail/jcms/c_684109/tyverb
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-09/tyverb_ct_5358.pdf
2008
false
France
French
English
guidelines for drug use
antineoplastic agents
protein kinase inhibitors
breast neoplasms
quinazolines
neoplasm metastasis
receptor, erbB-2
tablets
administration, oral
antineoplastic combined chemotherapy protocols
treatment outcome
survival analysis
insurance, health, reimbursement
lapatinib ditosylate
lapatinib
evaluation of the transparency committee
HER2 positive breast cancer
Lapatinib

---
http://oncomel.org/files/rbu%20hors%20GHS_onco_thoraciquef_072007.pdf
2007
true
France
French
carcinoma, small cell
carcinoma, non-small-cell lung
mesothelioma
thoracic neoplasms
antineoplastic agents
pleural neoplasms
guanine
glutamates
camptothecin
organoplatinum compounds
epirubicin
deoxycytidine
topotecan
vinblastine
paclitaxel
antineoplastic agents, phytogenic
taxoids
quinazolines
thiophenes
drug approval
antineoplastic agents
guidelines for drug use
table

---
https://www.cadth.ca/sites/default/files/pdf/278_gefitinib_cetap_f.pdf
2004
Canada
French
lung neoplasms
bronchial neoplasms
lung neoplasms
lung neoplasms
bronchial neoplasms
bronchial neoplasms
carcinoma, non-small-cell lung
antineoplastic agents
quinazolines
neoplasm metastasis
protein-tyrosine kinases
survival rate
canada
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
treatment outcome
antineoplastic agents
quinazolines
antineoplastic agents
quinazolines
clinical trials as topic
quinazolines
antineoplastic agents
enzyme inhibitors
enzyme inhibitors
enzyme inhibitors
enzyme inhibitors
Tyrosine Kinase Inhibitors
quinazolines
evaluation studies
journal article
table
Gefitinib

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.